0.4128
price down icon9.87%   -0.0452
after-market Handel nachbörslich: .43 0.0172 +4.17%
loading
Schlusskurs vom Vortag:
$0.458
Offen:
$0.44
24-Stunden-Volumen:
140.38K
Relative Volume:
0.26
Marktkapitalisierung:
$16.12M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-117.67M
KGV:
-0.1336
EPS:
-3.09
Netto-Cashflow:
$-101.06M
1W Leistung:
-4.22%
1M Leistung:
+39.93%
6M Leistung:
-20.48%
1J Leistung:
-87.53%
1-Tages-Spanne:
Value
$0.4122
$0.4494
1-Wochen-Bereich:
Value
$0.4122
$0.5074
52-Wochen-Spanne:
Value
$0.2195
$3.67

Athira Pharma Inc Stock (ATHA) Company Profile

Name
Firmenname
Athira Pharma Inc
Name
Telefon
(425) 620-8501
Name
Adresse
18706 NORTH CREEK PARKWAY, SUITE 104, BOTHELL
Name
Mitarbeiter
26
Name
Twitter
Name
Nächster Verdiensttermin
2024-12-07
Name
Neueste SEC-Einreichungen
Name
ATHA's Discussions on Twitter

Vergleichen Sie ATHA mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
ATHA
Athira Pharma Inc
0.4128 17.88M 0 -117.67M -101.06M -3.09
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
460.83 120.60B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
558.63 60.80B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
324.79 42.87B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
595.19 36.23B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
294.51 31.54B 3.81B -644.79M -669.77M -6.24

Athira Pharma Inc Stock (ATHA) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2024-09-19 Herabstufung Mizuho Outperform → Neutral
2024-09-04 Herabstufung BTIG Research Buy → Neutral
2024-09-04 Herabstufung JMP Securities Mkt Outperform → Mkt Perform
2024-09-04 Herabstufung Rodman & Renshaw Buy → Neutral
2024-08-19 Eingeleitet Rodman & Renshaw Buy
2022-10-17 Hochstufung JMP Securities Mkt Perform → Mkt Outperform
2022-07-07 Eingeleitet Mizuho Buy
2022-06-23 Herabstufung JMP Securities Mkt Outperform → Mkt Perform
2022-06-23 Herabstufung Jefferies Buy → Hold
2022-06-23 Herabstufung Stifel Buy → Hold
2022-05-10 Eingeleitet BTIG Research Buy
2022-04-21 Eingeleitet Berenberg Buy
2021-12-15 Eingeleitet Goldman Neutral
2020-10-13 Eingeleitet Goldman Buy
2020-10-13 Eingeleitet JMP Securities Mkt Outperform
2020-10-13 Eingeleitet Jefferies Buy
2020-10-13 Eingeleitet Stifel Buy
Alle ansehen

Athira Pharma Inc Aktie (ATHA) Neueste Nachrichten

pulisher
Jul 28, 2025

What are Athira Pharma Inc. company’s key revenue driversCapitalize on momentum-driven investment opportunities - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

Reversal indicators forming on Athira Pharma Inc. stockShort-Term Profit Alert With Entry Forecast - Newser

Jul 28, 2025
pulisher
Jul 28, 2025

Is it the right time to buy Athira Pharma Inc. stockGet daily expert analysis for smarter investing - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

Sector ETF performance correlation with Athira Pharma Inc. Smart Stock Forecast Using AI Algorithms - Newser

Jul 28, 2025
pulisher
Jul 27, 2025

What is Athira Pharma Inc. company’s growth strategyInvest confidently with expert support - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

What makes Athira Pharma Inc. stock price move sharplyUnlock exclusive investment alerts - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

What are the latest earnings results for Athira Pharma Inc.Unprecedented growth rates - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

Published on: 2025-07-27 20:04:45 - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

Athira Pharma Inc. Earnings Report Breakdown: What Investors Should KnowFree Trading Strategy Suggestions - Newser

Jul 27, 2025
pulisher
Jul 27, 2025

How Athira Pharma Inc. stock performs during market volatilitySolid Return Trade Selections - Newser

Jul 27, 2025
pulisher
Jul 27, 2025

Buy Signal for Athira Pharma Inc. Stock Key Technical Indicators to WatchFree Stock Market Return Analysis - Newser

Jul 27, 2025
pulisher
Jul 27, 2025

Why Athira Pharma Inc. stock attracts strong analyst attentionSteady Profit Stock Forecasts - Newser

Jul 27, 2025
pulisher
Jul 25, 2025

Is Athira Pharma Inc. a good long term investmentMarket-crushing profits - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 24, 2025

Athira Pharma Inc. Stock Analysis and ForecastUnprecedented profits - Autocar Professional

Jul 24, 2025
pulisher
Jul 24, 2025

What drives Athira Pharma Inc. stock priceHigh-yield capital appreciation - jammulinksnews.com

Jul 24, 2025
pulisher
Jul 23, 2025

What analysts say about Athira Pharma Inc. stockSkyrocketing investment returns - jammulinksnews.com

Jul 23, 2025
pulisher
Jul 23, 2025

Athira Pharma (NASDAQ:ATHA) Trading Up 8.4% – Here’s Why - Defense World

Jul 23, 2025
pulisher
Jul 17, 2025

Investors Can Still File Late Claims in Athira Pharma Settlement — Here’s How to Get Your Share - TradingView

Jul 17, 2025
pulisher
Jul 16, 2025

Lewy Body Dementia Market Set to Grow Substantially Through - openPR.com

Jul 16, 2025
pulisher
Jul 10, 2025

Athira Pharma (ATHA) Is Paying a $10M Settlement to Investors — Here’s How to Get Your Share - TradingView

Jul 10, 2025
pulisher
Jun 25, 2025

Is Athira Pharma, Inc. technically bullish or bearish? - MarketsMojo

Jun 25, 2025
pulisher
Jun 08, 2025

Two Sigma Advisers LP Has $149,000 Position in Athira Pharma, Inc. (NASDAQ:ATHA) - Defense World

Jun 08, 2025
pulisher
Jun 07, 2025

ATHA LOSS ALERT: ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Athira Pharma, Inc. Investors with LARGE LOSSES to Secure Counsel Before Important Deadline in Securities Class Action – ATHA - ACCESS Newswire

Jun 07, 2025
pulisher
Jun 05, 2025

12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga

Jun 05, 2025
pulisher
Jun 05, 2025

Athira Pharma (NASDAQ:ATHA) Trading 9.2% Higher – Here’s Why - Defense World

Jun 05, 2025
pulisher
Jun 04, 2025

HAGENS BERMAN, NATIONAL ATTORNEYS, Alerts Athira Pharma (ATHA) Investors to Filing Of Securities Class Action, Advises Investors with Losses to Contact Firm's Attorneys Now - ACCESS Newswire

Jun 04, 2025
pulisher
Jun 03, 2025

Athira Pharma Presents Data from ACT-AD Phase 2 Proof-of-Concept Clinical Study of Fosgonimeton in Mild-to-Moderate Alzheimer’s Patients at the Alzheimer's Association International Conference 2022 - Barchart.com

Jun 03, 2025
pulisher
Jun 02, 2025

Athira Pharma Holds Annual Stockholders Meeting - TipRanks

Jun 02, 2025
pulisher
Jun 01, 2025

Athira Pharma Presents Preclinical Data at the Alzheimer's Association International Conference 2022 - Barchart.com

Jun 01, 2025
pulisher
May 27, 2025

This Athira Pharma Insider Increased Their Holding By 111% Last Year - Yahoo Finance

May 27, 2025
pulisher
May 20, 2025

Athira Pharma’s SWOT analysis: als drug developer’s stock faces pivotal phase - Investing.com

May 20, 2025
pulisher
May 15, 2025

Athira Pharma (ATHA) Highlights Promising Phase 1 Results for ALS Drug Candidate | ATHA Stock News - GuruFocus

May 15, 2025
pulisher
May 14, 2025

Athira Pharma to present data from first-in-human Phase 1 trial of ATH-1105 - Yahoo Finance

May 14, 2025
pulisher
May 14, 2025

Athira Pharma (ATHA) Projected to Post Earnings on Wednesday - Defense World

May 14, 2025
pulisher
May 14, 2025

Athira Pharma Reports Reduced Losses and Strategic Focus - MSN

May 14, 2025

Finanzdaten der Athira Pharma Inc-Aktie (ATHA)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$23.09
price down icon 1.32%
$37.06
price up icon 1.06%
$101.75
price down icon 2.12%
$27.45
price down icon 4.26%
$112.79
price down icon 2.19%
biotechnology ONC
$294.51
price up icon 1.04%
Kapitalisierung:     |  Volumen (24h):